The Europe sequencing reagents market growth is anticipated to progress at a CAGR of 13.08% during the forecast period, 2021-2028. The rising government initiatives have led to increased R&D activities. This, along with the thriving biotechnology industry, drives the market growth.

EUROPE SEQUENCING REAGENTS MARKET FORECAST 2021-2028

Europe Sequencing Reagents Market by Technology (Next-generation Sequencing, Sanger Sequencing, Third-generation Sequencing) Market by Reagent Type (Sequencing Kits, Control Kits, Library Kits, Template Kits, Other Reagent Types) Market by Application (Oncology, Clinical Investigation, Agri Genomics and Forensics, Reproductive Health, Other Applications) Market by End-user (Research Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-users) by Geography

Request free sample

Report Summary

To learn more about this report, request a free sample copy

The Europe sequencing reagents market growth assessment includes the analysis of the United Kingdom, Belgium, Russia, Poland, France, Germany, Italy, and Rest of Europe. In the United Kingdom, the rapidly advancing healthcare and the growing specialized therapies in medical disorders like autoimmune diseases and cancer due to government initiatives contribute to the market growth. As a result, the rising prevalence of cancer impacts market growth. Additionally, government and non-government investments in genome sequencing R&D benefits market growth. For example, the Wellcome Sanger Institute announced £9.4 million in funding in November 2019 to supplement the launch of the first phase of sequencing for the Darwin Tree of Life Project.

In Italy, the increasing awareness about the sequencing reagents’ benefits with regard to cancer and the thriving biotech industry propels the market growth. Also, the innovations by the regional companies, the competent academic and industrial research, and increased R&D expenditure contribute to the biotech industry growth. In addition, the biotech sector encompasses small and medium-size companies and innovative start-ups.

F. Hoffmann-La Roche Ltd develops therapeutic and diagnostic products. Also, it manufactures pharmaceutical products in neuroscience, immunology, infectious diseases, ophthalmology, and oncology. The company has business operations in Latin America, Oceania, Australia, Africa, Asia, North America, Europe, etc., with headquarters in Basel, Switzerland.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- KEY DRIVERS
  - ADVANCED SEQUENCING METHODS LOWER THE COST OF SEQUENCING PROCEDURES
  - CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
  - PREVALENCE OF CHRONIC DISEASES
- KEY RESTRAINTS
  - LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE
  - SOCIAL AND ETHICAL ISSUES RELATED TO THE DATA PRIVACY

KEY ANALYTICS
- IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - BUYERS POWER
  - SUPPLIERS POWER
  - SUBSTITUTION
  - NEW ENTRY
  - INDUSTRY RIVALRY
- SUPPLY CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
MARKET BY TECHNOLOGY
- NEXT-GENERATION SEQUENCING
- SANGER SEQUENCING
- THIRD-GENERATION SEQUENCING
MARKET BY REAGENT TYPE
- SEQUENCING KITS
- CONTROL KITS
- LIBRARY KITS
- TEMPLATE KITS
- OTHER REAGENT TYPES
MARKET BY APPLICATION
- ONCOLOGY
- CLINICAL INVESTIGATION
- AGRI GENOMICS AND FORENSICS
- REPRODUCTIVE HEALTH
- OTHER APPLICATIONS
MARKET BY END-USER
- RESEARCH INSTITUTES
- HOSPITALS AND CLINICS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- OTHER END-USERS
GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - GERMANY
    - FRANCE
    - UNITED KINGDOM
    - ITALY
    - RUSSIA
    - POLAND
    - BELGIUM
    - REST OF EUROPE

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - MERGERS & ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS & AGREEMENTS
  - BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
  - AGILENT TECHNOLOGIES INC
  - ASURAGEN INC
  - BGI GENOMICS
  - BIO-RAD LABORATORIES INC
  - HOFFMANN-LA ROCHE
  - FLUIDIGM CORPORATION
  - ILLUMINA INC
  - LGC BIOSEARCH TECHNOLOGIES
  - MERCK KGAA
  - PACIFIC BIOSCIENCES OF CALIFORNIA INC
  - PERKINELMER INC
  - QIAGEN NV
  - TAKARA BIO INC
  - THERMO FISHER SCIENTIFIC INC
  - TRILINK BIOTECHNOLOGIES INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – SEQUENCING REAGENTS

TABLE 2: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE SEQUENCING REAGENTS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: EUROPE SEQUENCING REAGENTS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE SEQUENCING REAGENTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: EUROPE SEQUENCING REAGENTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: LEADING PLAYERS OPERATING IN EUROPE SEQUENCING REAGENTS MARKET

TABLE 13: LIST OF MERGERS & ACQUISITIONS

TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 16: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 6: EUROPE SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, IN 2020

FIGURE 10: EUROPE SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, IN 2020

FIGURE 16: EUROPE SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE SEQUENCING REAGENTS MARKET, BY END-USER, IN 2020

FIGURE 22: EUROPE SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: GERMANY SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: FRANCE SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: UNITED KINGDOM SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: ITALY SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: RUSSIA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: POLAND SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: BELGIUM SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: REST OF EUROPE SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGE
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - GERMANY
    - FRANCE
    - UNITED KINGDOM
    - ITALY
    - RUSSIA
    - POLAND
    - BELGIUM
    - REST OF EUROPE

MARKET BY TECHNOLOGY
- NEXT-GENERATION SEQUENCING
- SANGER SEQUENCING
- THIRD-GENERATION SEQUENCING
MARKET BY REAGENT TYPE
- SEQUENCING KITS
- CONTROL KITS
- LIBRARY KITS
- TEMPLATE KITS
- OTHER REAGENT TYPES
MARKET BY APPLICATION
- ONCOLOGY
- CLINICAL INVESTIGATION
- AGRI GENOMICS AND FORENSICS
- REPRODUCTIVE HEALTH
- OTHER APPLICATIONS
MARKET BY END-USER
- RESEARCH INSTITUTES
- HOSPITALS AND CLINICS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- OTHER END-USERS

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.